Core Historical Income Statement

CLB Stock  USD 19.89  0.38  1.87%   
Historical analysis of Core Laboratories income statement accounts such as Interest Expense of 10.1 M, Selling General Administrative of 34.6 M or Total Revenue of 619.3 M can show how well Core Laboratories NV performed in making a profits. Evaluating Core Laboratories income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Core Laboratories's future profits or losses.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Core Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Core Laboratories is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Core Income Statement Analysis

Core Laboratories Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Core Laboratories shareholders. The income statement also shows Core investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Core Laboratories Income Statement Chart

At present, Core Laboratories' Depreciation And Amortization is projected to decrease significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 619.3 M, whereas Interest Expense is forecasted to decline to about 10.1 M.

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Core Laboratories NV minus its cost of goods sold. It is profit before Core Laboratories operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most accounts from Core Laboratories' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Core Laboratories current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At present, Core Laboratories' Depreciation And Amortization is projected to decrease significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 619.3 M, whereas Interest Expense is forecasted to decline to about 10.1 M.
 2021 2022 2023 2024 (projected)
Gross Profit83.8M78.9M94.0M171.1M
Total Revenue470.3M489.7M509.8M619.3M

Core Laboratories income statement Correlations

0.090.070.470.480.420.470.330.40.440.140.39-0.120.320.54-0.36-0.430.210.340.31-0.17-0.630.24-0.620.03-0.06
0.090.720.340.110.530.03-0.03-0.020.510.64-0.08-0.44-0.05-0.12-0.850.2-0.380.82-0.520.250.37-0.470.38-0.26-0.05
0.070.720.680.50.810.430.470.460.790.890.42-0.040.430.35-0.830.450.130.86-0.010.10.21-0.020.20.090.15
0.470.340.680.960.970.930.90.910.980.720.890.220.870.84-0.620.040.660.650.40.18-0.080.08-0.110.410.13
0.480.110.50.960.880.980.940.950.890.590.950.320.920.92-0.410.00.790.440.570.18-0.190.14-0.230.510.14
0.420.530.810.970.880.820.80.811.00.820.780.130.780.72-0.770.090.50.80.240.160.030.030.00.310.12
0.470.030.430.930.980.820.960.970.840.480.960.410.930.95-0.32-0.030.840.390.620.23-0.210.21-0.260.580.28
0.33-0.030.470.90.940.80.961.00.820.521.00.460.990.9-0.280.030.910.340.610.12-0.120.29-0.160.570.25
0.4-0.020.460.910.950.810.971.00.830.521.00.430.990.92-0.30.00.90.360.620.1-0.170.3-0.210.560.24
0.440.510.790.980.891.00.840.820.830.790.790.130.790.73-0.760.070.520.780.250.160.020.03-0.010.320.12
0.140.640.890.720.590.820.480.520.520.790.480.010.490.4-0.790.390.20.790.070.050.13-0.040.120.110.01
0.39-0.080.420.890.950.780.961.01.00.790.480.450.990.92-0.25-0.010.920.310.650.09-0.190.32-0.220.560.24
-0.12-0.44-0.040.220.320.130.410.460.430.130.010.450.430.470.210.240.52-0.130.45-0.01-0.230.33-0.260.480.28
0.32-0.050.430.870.920.780.930.990.990.790.490.990.430.86-0.25-0.020.930.30.570.1-0.080.28-0.120.560.21
0.54-0.120.350.840.920.720.950.90.920.730.40.920.470.86-0.240.00.80.310.770.07-0.460.39-0.490.520.29
-0.36-0.85-0.83-0.62-0.41-0.77-0.32-0.28-0.3-0.76-0.79-0.250.21-0.25-0.24-0.070.12-0.970.260.06-0.140.1-0.150.190.07
-0.430.20.450.040.00.09-0.030.030.00.070.39-0.010.24-0.020.0-0.07-0.040.10.130.25-0.01-0.21-0.020.080.11
0.21-0.380.130.660.790.50.840.910.90.520.20.920.520.930.80.12-0.04-0.060.70.12-0.150.33-0.190.650.25
0.340.820.860.650.440.80.390.340.360.780.790.31-0.130.30.31-0.970.1-0.06-0.160.070.150.010.15-0.020.17
0.31-0.52-0.010.40.570.240.620.610.620.250.070.650.450.570.770.260.130.7-0.160.0-0.650.58-0.690.630.38
-0.170.250.10.180.180.160.230.120.10.160.050.09-0.010.10.070.060.250.120.070.00.37-0.520.30.480.5
-0.630.370.21-0.08-0.190.03-0.21-0.12-0.170.020.13-0.19-0.23-0.08-0.46-0.14-0.01-0.150.15-0.650.37-0.421.0-0.030.07
0.24-0.47-0.020.080.140.030.210.290.30.03-0.040.320.330.280.390.1-0.210.330.010.58-0.52-0.42-0.420.290.44
-0.620.380.2-0.11-0.230.0-0.26-0.16-0.21-0.010.12-0.22-0.26-0.12-0.49-0.15-0.02-0.190.15-0.690.31.0-0.42-0.110.01
0.03-0.260.090.410.510.310.580.570.560.320.110.560.480.560.520.190.080.65-0.020.630.48-0.030.29-0.110.66
-0.06-0.050.150.130.140.120.280.250.240.120.010.240.280.210.290.070.110.250.170.380.50.070.440.010.66
Click cells to compare fundamentals

Core Laboratories Account Relationship Matchups

Core Laboratories income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization171.9K20.9M18.5M17.2M15.8M19.2M
Interest Expense14.7M14.4M9.2M11.6M13.4M10.1M
Selling General Administrative48.0M34.0M44.2M38.1M40.3M34.6M
Total Revenue668.2M487.3M470.3M489.7M509.8M619.3M
Gross Profit150.0M91.6M83.8M78.9M94.0M171.1M
Other Operating Expenses566.2M429.7M430.6M448.2M455.2M493.9M
Operating Income96.7M55.8M45.3M41.5M54.6M51.9M
Ebit119.1M(77.4M)45.3M41.5M54.6M51.9M
Ebitda119.3M(56.5M)63.8M58.7M70.4M66.9M
Cost Of Revenue518.2M395.6M386.4M410.8M415.7M448.2M
Total Operating Expenses48.0M34.0M44.2M37.4M39.4M45.7M
Income Before Tax82.0M(91.2M)36.1M30.0M41.2M39.1M
Total Other Income Expense Net(14.7M)(14.4M)(9.2M)(11.6M)(13.4M)(12.8M)
Net Income102.0M(97.1M)19.7M19.5M36.7M34.8M
Income Tax Expense(12.3M)5.9M15.9M10.3M4.2M4.0M
Net Income Applicable To Common Shares102.0M(97.6M)19.7M19.5M22.4M21.3M
Minority Interest134K140K(492K)(205K)(350K)(332.5K)
Net Income From Continuing Ops94.3M(97.1M)20.2M19.7M37.0M35.2M
Tax Provision(12.3M)5.9M15.9M10.3M4.2M4.0M
Interest Income14.7M14.4M9.2M11.6M10.4M9.8M
Discontinued Operations2.1M(58K)7.8M(424K)(487.6K)(463.2K)
Net Interest Income(14.7M)(14.4M)(9.2M)(11.6M)(13.4M)(14.1M)
Reconciled Depreciation22.6M20.9M18.5M17.2M15.8M16.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.316
Dividend Share
0.04
Earnings Share
0.54
Revenue Per Share
11.158
Quarterly Revenue Growth
0.072
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.